Stock comparison
LeMaitre Vascular
Mettler-Toledo International
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LMAT
LeMaitre Vascular
Market cap
$2.23B
Sector
Healthcare
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
Overall winner
LeMaitre Vascular LMAT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LMAT | MTD | Winner |
|---|---|---|---|
| Warren Buffett | 77B | 69B | LMAT |
| Benjamin Graham | 89A | 65B | LMAT |
| Philip Fisher | 81C | 63C | LMAT |
| Peter Lynch | 67B | 66B | LMAT |
| Joel Greenblatt | 56D | 68B | MTD |
| Charlie Munger | 68D | 74B | MTD |
| Terry Smith | 69D | 70B | MTD |
Side-by-side metrics
| Metric | LMAT | MTD |
|---|---|---|
| Market cap | $2.23B | $22.29B |
| P/E (TTM) | 37.1x | 25.3x |
| EV/EBIT | 36.6x | 21.6x |
| ROIC (TTM) | 9.43% | 36.09% |
| Gross margin | 72.39% | 57.79% |
| Net margin | 24.35% | 21.4% |
| Revenue CAGR 5y | 12.75% | 2.01% |
| EPS CAGR 5y | 19.04% | 6.12% |
| Debt / Equity | 0.5x | - |
| Dividend yield | 0.84% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LMAT leads on
- Dividend yield0.84%vs 0.0%+100%
- Revenue CAGR 5y12.75%vs 2.01%+84%
- EPS CAGR 5y19.04%vs 6.12%+68%
- Gross margin72.39%vs 57.79%+20%
MTD leads on
- Debt / Equity-vs 0.5x+101%
- Market cap$22.29Bvs $2.23B+90%
- ROIC (TTM)36.09%vs 9.43%+74%
- EV/EBIT21.6xvs 36.6x+41%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.